ClinicalTrials.Veeva

Menu

Clariance ErYs Registry

C

Clariance

Status

Enrolling

Conditions

Spinal Tumor
Spinal Fracture
Spine Degeneration
Spinal Deformity
Spine Spondylosis Thoracic

Treatments

Procedure: Spine surgery

Study type

Observational

Funder types

Industry

Identifiers

NCT05170815
CSS-2021-01

Details and patient eligibility

About

International, prospective, single arm, multicenter and observational Post-Market Clinical Follow-up (PMCF).

The overall objective of this study is to collect preoperative, intraoperative and postoperative (at 9 weeks, 6 months, 1 year and 2 years) data on the clinical complications and functional outcomes of the study devices to demonstrate safety and performance in a real-world setting.

The primary objective is to demonstrate that the use of the study devices is safe.

The secondary objective is to demonstrate that the use of the study devices decreases the pain, and improves the quality of life and the daily activities of the subjects.

Enrollment

760 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Considered as adult in the respective geography (18 years old or older for France and 21 years old or older for United-States).
  • Indicated for treatment with one or more commercially available sponsor spine device included into the study.
  • For France only, affiliated with or beneficiary of a social security scheme.

Exclusion criteria

  • Subjects who are not able to comply with the study procedures based on the judgment of the investigator (e.g., inability to comprehend study related questions, inability to keep scheduled assessment times).
  • Subjects who are considered as vulnerable: minor, pregnant woman or people under legal protection (guardianship or curatorship).
  • Contraindicated for spine surgery utilizing a commercially available sponsor spine device.

Trial design

760 participants in 11 patient groups

ERISMA® LP/LP EVO
Description:
120 subjects with ERISMA® LP/LP EVO implant
Treatment:
Procedure: Spine surgery
ERISMA® Deformity
Description:
120 subjects with ERISMA® Deformity implant
Treatment:
Procedure: Spine surgery
ERISMA® MIS
Description:
120 subjects with ERISMA® MIS implant
Treatment:
Procedure: Spine surgery
Idys® TLIF PEEK
Description:
50 subjects with Idys® TLIF PEEK implant
Treatment:
Procedure: Spine surgery
Idys® TLIF TiVAC
Description:
50 subjects with Idys® TLIF TiVAC implant
Treatment:
Procedure: Spine surgery
Idys® TLIF 3DTi
Description:
50 subjects with Idys® TLIF 3DTi implant
Treatment:
Procedure: Spine surgery
Idys® ALIF PEEK
Description:
50 subjects with Idys® ALIF PEEK implant
Treatment:
Procedure: Spine surgery
Idys® ALIF TiVAC
Description:
50 subjects with Idys® ALIF TiVAC implant
Treatment:
Procedure: Spine surgery
Idys® ALIF 3DTi
Description:
50 subjects with Idys® ALIF 3DTi implant
Treatment:
Procedure: Spine surgery
Idys® ALIF ZP 3DTi
Description:
50 subjects with Idys® ALIF ZP 3DTi implant
Treatment:
Procedure: Spine surgery
Idys® LLIF 3DTi
Description:
50 subjects with Idys® LLIF 3DTi implant
Treatment:
Procedure: Spine surgery

Trial contacts and locations

1

Loading...

Central trial contact

Florian Laboulfie

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems